Seroprevalence of Human Brucellosis among Syrian Refugees in Jordan, 2022

Table 3

The difference in reported symptoms (within 6 months of the date of data collection) between the Brucella IgG-positive and IgG-negative cohorts.

Symptoms	IgG-positive (N = 149)	IgG-negative (N = 1411)	P value
Experienced any brucellosis symptoms	9 (6.0%)	40 (2.8%)	0.045
Undulant fever	8 (5.4%)	22 (1.6%)	0.005
Chills	3 (2.0%)	18 (1.3%)	0.444
Headache	8 (5.4%)	21 (1.5%)	0.004
Joint pain	8 (5.4%)	29 (2.1%)	0.020
Loss of appetite	5 (3.4%)	15 (1.1%)	0.035
Malaise	2 (1.2%)	17 (1.3%)	0.702
Myalgia	3 (2.0%)	19 (1.3%)	0.511
Back pain	4 (2.7%)	20 (1.4%)	0.278
Depression	2 (1.3%)	10 (0.7%)	0.320